Implant Sciences Continues Sales Into Africa for Corporate Security
(firmenpresse) - WILMINGTON, MA -- (Marketwire) -- 10/11/12 -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold its Quantum Sniffer™ QS-H150 to another new customer for deployment in Africa. The handheld explosives trace detector was purchased by a European-headquartered global electronics manufacturer for use in corporate security at its facilities in Nigeria.
The sale was made by Implant Sciences' distributor, Lunasat through its in-country partner Guardia. Lunasat has offices in Los Angeles, Beirut and Baghdad and is a leading provider of communications services throughout the Middle East and Africa.
"The investment Implant Sciences has made in growing its distribution network continues to pay dividends, as demonstrated by the steady growth in our Africa business," stated Implant Sciences' Vice President of Global Sales and Marketing, Dr. Darryl Jones. "We appreciate the efforts of Lunasat and Guardia in helping us expand our market coverage."
The Quantum Sniffer QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company's QS-B220 desktop explosives and drugs trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-Terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at .
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.
Implant Sciences Corporation
Company Contact:
Glenn Bolduc
CEO
978-752-1700
or
Investor Contact:
Laurel Moody
646-810-0608
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.10.2012 - 05:00 Uhr
Sprache: Deutsch
News-ID 1159169
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
WILMINGTON, MA
Phone:
Kategorie:
Aircraft
Anmerkungen:
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Implant Sciences Continues Sales Into Africa for Corporate Security
"
steht unter der journalistisch-redaktionellen Verantwortung von
Implant Sciences Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
